« Back Nanomedicine: Nanotechnology, Biology and Medicine

Article in Press

ERα signaling imparts chemotherapeutic selectivity to selenium nanoparticles in breast cancer

  • Kiritkumar K. Vekariya, MSPharm
    • ,
  • Jasmine Kaur, MSc
    • ,
  • Kulbhushan Tikoo, PhD

      Affiliations

    • Corresponding Author InformationCorresponding author: Laboratory of Chromatin Biology, Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab-160062, India.

Received 22 August 2011 ,Accepted 9 December 2011. Published online 26 December 2011 Corrected Proof

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This research was supported by the Department of Science and Technology and the National National Institute of Pharmaceutical Education and Research.

PII: S1549-9634(11)00598-3

doi: 10.1016/j.nano.2011.12.003

« Back Nanomedicine: Nanotechnology, Biology and Medicine

Article in Press

Article Tools

* Image Usage & Resolution